References
- Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. Who analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–1074.
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–1594.
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
- Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–1249.
- Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003;59:153–160.
- Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505–1512.
- Ohkuchi A, Minakami H, Aoya T, Haga T, Kimura H, Suzuki M, Sato I. Expansion of the fraction of Th1 cells in women with preeclampsia: inverse correlation between the percentage of Th1 cells and the plasma level of PAI-2. Am J Reprod Immunol 2001;46:252–259.
- Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003;59:161–173.
- Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy 2005;89:49–61.
- Ceyhan T, Beyan C, Baser I, Kaptan K, Gungor S, Ifran A. The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume. Ann Hematol 2006;85:320–322.
- Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest 1998;45:229–231.
- Matsuo K, Ushioda N, Harman CR, Kimura T. Increased leukocyte distribution in the pre-clinical stage of pre-eclampsia. Int J Gynaecol Obstet 2007;96:31–32.
- Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591–594.
- von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100:27–40.
- Lukanov TH, Bojinova SI, Emin AL, Veleva GL, Popova VS, Konova EI. Upregulation of the CD40-CD40 ligand system in pre-eclampsia. Int J Gynaecol Obstet 2009;105:257–260.
- Koenen RR, Weber C. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin Thromb Hemost. 2010; 36:163–169.
- Dundar O, Yoruk P, Tutuncu L, Erikci AA, Muhcu M, Ergur AR, Atay V, Mungen E. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia. Prenat Diagn 2008;28:1052–1056.
- Norris LA, Gleeson N, Sheppard BL, Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia. Br J Obstet Gynaecol 1993;100:684–688.
- Stubbs TM, Lazarchick J, Van Dorsten JP, Cox J, Loadholt CB. Evidence of accelerated platelet production and consumption in nonthrombocytopenic pre-eclampsia. Am J Obstet Gynecol 1986;155:263–265.
- Hutt R, Ogunniyi SO, Sullivan LHF, Elder MG. Increased platelet volume and aggregation precede the onset of pre-eclampsia. Obstet Gynecol 1994;83:146–149.
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. J Obstet Gynecol 2000;183:S1–S22.
- Herrera JA, Chaudhuri G, Lopez-Jaramillo P. Is infection a major risk factor for preeclampsia? Med Hypotheses 2001;57: 393–397.